// App-Quantinova.ai

4543 : Effect of KIR Ligand Mismatched SCT for Infantile ALL with MLL gene Rearrangement: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Researchers

Presenter

  • Masahiro Hirayama

Principal Investigators

  • Kanji Sugita

  • Tomoyuki Watanabe

  • Eiichi Ishii

  • Katsuyoshi Koh

  • Koji Kato

  • Akiko Moriya Saito

  • Keizo Horibe

  • Masahito Tsurusawa

  • Daisuke Tomizawa

Medical Centers

  • Department of Surgical Specialties, Tokyo Medical and Dental University, Tokyo, Japan

  • NPO-OSCR data center, Nagoya, Japan

  • Laboratory of Clinical, Epidemiological and Health Services Research Clinical Research Center, National Hospital Organization, Japan, Japan

  • Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan

  • Japanese Pediatric Leukemia/Lymphoma Study Group, Nagoya, Japan

  • Department of Hematology and Oncology, Japanese Red Cross Nagoya First Hospital, Children's Medical Center, Nagoya, Japan

  • Clinical Rsch Cntr, National Hosp Organization, Nagoya Med Cntr, Nagoya, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Lymphomas

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved